201 related articles for article (PubMed ID: 37770589)
1. iPSC-derived type IV collagen α5-expressing kidney organoids model Alport syndrome.
Hirayama R; Toyohara K; Watanabe K; Otsuki T; Araoka T; Mae SI; Horinouchi T; Yamamura T; Okita K; Hotta A; Iijima K; Nozu K; Osafune K
Commun Biol; 2023 Sep; 6(1):854. PubMed ID: 37770589
[TBL] [Abstract][Full Text] [Related]
2. Loss of alpha3/alpha4(IV) collagen from the glomerular basement membrane induces a strain-dependent isoform switch to alpha5alpha6(IV) collagen associated with longer renal survival in Col4a3-/- Alport mice.
Kang JS; Wang XP; Miner JH; Morello R; Sado Y; Abrahamson DR; Borza DB
J Am Soc Nephrol; 2006 Jul; 17(7):1962-9. PubMed ID: 16769745
[TBL] [Abstract][Full Text] [Related]
3. Endothelial cell-specific collagen type IV-α
Funk SD; Bayer RH; Miner JH
Am J Physiol Renal Physiol; 2019 May; 316(5):F830-F837. PubMed ID: 30724107
[TBL] [Abstract][Full Text] [Related]
4. A human-mouse chimera of the alpha3alpha4alpha5(IV) collagen protomer rescues the renal phenotype in Col4a3-/- Alport mice.
Heidet L; Borza DB; Jouin M; Sich M; Mattei MG; Sado Y; Hudson BG; Hastie N; Antignac C; Gubler MC
Am J Pathol; 2003 Oct; 163(4):1633-44. PubMed ID: 14507670
[TBL] [Abstract][Full Text] [Related]
5. [Alport syndrome: Hereditary nephropathy associated with mutations in genes coding for type IV collagen chains].
Heidet L; Gubler MC
Nephrol Ther; 2016 Dec; 12(7):544-551. PubMed ID: 27816395
[TBL] [Abstract][Full Text] [Related]
6. Upregulated expression of integrin α1 in mesangial cells and integrin α3 and vimentin in podocytes of Col4a3-null (Alport) mice.
Steenhard BM; Vanacore R; Friedman D; Zelenchuk A; Stroganova L; Isom K; St John PL; Hudson BG; Abrahamson DR
PLoS One; 2012; 7(12):e50745. PubMed ID: 23236390
[TBL] [Abstract][Full Text] [Related]
7. A COL4A3 gene mutation and post-transplant anti-alpha 3(IV) collagen alloantibodies in Alport syndrome.
Kalluri R; van den Heuvel LP; Smeets HJ; Schroder CH; Lemmink HH; Boutaud A; Neilson EG; Hudson BG
Kidney Int; 1995 Apr; 47(4):1199-204. PubMed ID: 7783419
[TBL] [Abstract][Full Text] [Related]
8. Collagen IV diseases: A focus on the glomerular basement membrane in Alport syndrome.
Cosgrove D; Liu S
Matrix Biol; 2017 Jan; 57-58():45-54. PubMed ID: 27576055
[TBL] [Abstract][Full Text] [Related]
9. Autosomal dominant form of type IV collagen nephropathy exists among patients with hereditary nephritis difficult to diagnose clinicopathologically.
Imafuku A; Nozu K; Sawa N; Hasegawa E; Hiramatsu R; Kawada M; Hoshino J; Tanaka K; Ishii Y; Takaichi K; Fujii T; Ohashi K; Iijima K; Ubara Y
Nephrology (Carlton); 2018 Oct; 23(10):940-947. PubMed ID: 28704582
[TBL] [Abstract][Full Text] [Related]
10. Milder clinical aspects of X-linked Alport syndrome in men positive for the collagen IV α5 chain.
Hashimura Y; Nozu K; Kaito H; Nakanishi K; Fu XJ; Ohtsubo H; Hashimoto F; Oka M; Ninchoji T; Ishimori S; Morisada N; Matsunoshita N; Kamiyoshi N; Yoshikawa N; Iijima K
Kidney Int; 2014 May; 85(5):1208-13. PubMed ID: 24304881
[TBL] [Abstract][Full Text] [Related]
11. Genetic reprogramming with stem cells regenerates glomerular epithelial podocytes in Alport syndrome.
LeBleu VS; Kanasaki K; Lovisa S; Alge JL; Kim J; Chen Y; Teng Y; Gerami-Naini B; Sugimoto H; Kato N; Revuelta I; Grau N; Sleeman JP; Taduri G; Kizu A; Rafii S; Hochedlinger K; Quaggin SE; Kalluri R
Life Sci Alliance; 2024 Jun; 7(6):. PubMed ID: 38561223
[TBL] [Abstract][Full Text] [Related]
12. X-linked Alport Syndrome with Type IV Collagen α5 Chain Staining Revealing Normal Expression in the Glomerular Basement Membrane and Negative on Bowman's Capsule and Distal Tubular Basement Membrane: A Case Report.
Okamoto T; Shima H; Doi T; Nozu K; Inoue T; Tashiro M; Wariishi S; Bando H; Azuma H; Iwasaka N; Ohara T; Okada K; Minakuchi J
Tohoku J Exp Med; 2023 Sep; 261(1):69-73. PubMed ID: 37495524
[TBL] [Abstract][Full Text] [Related]
13. A mouse Col4a4 mutation causing Alport glomerulosclerosis with abnormal collagen α3α4α5(IV) trimers.
Korstanje R; Caputo CR; Doty RA; Cook SA; Bronson RT; Davisson MT; Miner JH
Kidney Int; 2014 Jun; 85(6):1461-8. PubMed ID: 24522496
[TBL] [Abstract][Full Text] [Related]
14. Possible Digenic Disease in a Caucasian Family with COL4A3 and COL4A5 Mutations.
Choi M; Anistan YM; Eckardt KU; Gollasch M; Nickel P
Nephron; 2019; 141(3):213-218. PubMed ID: 30661074
[TBL] [Abstract][Full Text] [Related]
15. Loss of the BMP antagonist USAG-1 ameliorates disease in a mouse model of the progressive hereditary kidney disease Alport syndrome.
Tanaka M; Asada M; Higashi AY; Nakamura J; Oguchi A; Tomita M; Yamada S; Asada N; Takase M; Okuda T; Kawachi H; Economides AN; Robertson E; Takahashi S; Sakurai T; Goldschmeding R; Muso E; Fukatsu A; Kita T; Yanagita M
J Clin Invest; 2010 Mar; 120(3):768-77. PubMed ID: 20197625
[TBL] [Abstract][Full Text] [Related]
16. A novel Cys1638Tyr NC1 domain substitution in alpha5(IV) collagen causes Alport syndrome with late onset renal failure without hearing loss or eye abnormalities.
Wilson JC; Yoon HS; Walker RJ; Eccles MR
Nephrol Dial Transplant; 2007 May; 22(5):1338-46. PubMed ID: 17277342
[TBL] [Abstract][Full Text] [Related]
17. Generation of the induced pluripotent stem cell line (NCKDi004-A) from a 17-year-old patient with Alport syndrome carrying a homozygous mutation in COL4A3 gene.
Wu H; Wang G; Gao E; Zhang L; Zhu Y; Zhang J; Liu Z
Stem Cell Res; 2021 Oct; 56():102557. PubMed ID: 34626894
[TBL] [Abstract][Full Text] [Related]
18. Generation and characterization of an integration-free iPSC line SDUBMSi006-A from a patient with Alport syndrome caused by COL4A3 gene mutations.
Ma Y; Wang Z; Liu X; Sun W; Gong Y; Liu G; Sun G
Stem Cell Res; 2021 Apr; 52():102237. PubMed ID: 33601099
[TBL] [Abstract][Full Text] [Related]
19. A COL4A4-G394S Variant and Impaired Collagen IV Trimerization in a Patient with Mild Alport Syndrome.
Kohler J; Omachi K; Charu V; Miner JH; Bhalla V
Kidney360; 2022 Nov; 3(11):1899-1908. PubMed ID: 36514391
[TBL] [Abstract][Full Text] [Related]
20. X-linked Alport syndrome associated with a synonymous p.Gly292Gly mutation alters the splicing donor site of the type IV collagen alpha chain 5 gene.
Fu XJ; Nozu K; Eguchi A; Nozu Y; Morisada N; Shono A; Taniguchi-Ikeda M; Shima Y; Nakanishi K; Vorechovsky I; Iijima K
Clin Exp Nephrol; 2016 Oct; 20(5):699-702. PubMed ID: 26581810
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]